NCT05139459View on ClinicalTrials.gov

Sepsis Characterization in Kilimanjaro

CompletedOBSERVATIONAL

Enrollment

499

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

November 3, 2023

Study Completion Date

November 3, 2023

Conditions

Sepsis

Trial Locations (1)

27706

Duke University Medical Centre, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Kilimanjaro Christian Medical Centre, Tanzania

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Duke University

OTHER

NCT05139459 - Sepsis Characterization in Kilimanjaro | Biotech Hunter | Biotech Hunter